“Observer investigation shows that majority of Nice drug appraisals involve groups financially linked to maker of pharmaceuticals“ Shanti Das and Jon Ungoed-Thomas report for The Observer: “Drug companies are systematically funding grassroots patient groups that lobby the NHS medicines watchdog to approve…
Read more
This leader-article comes from The Economist. It begins: “Almost 35 years ago American drug regulators approved Prozac, the first in a series of blockbuster antidepressants known as selective serotonin re-uptake inhibitors (SSRIs). Prozac and its cousins were lauded by patients and…
Read more
This free course (from Mad in America Continuing Education) includes a lecture video from Prof. Irving Kirsch (Associate Director of the Program in Placebo Studies and lecturer in medicine at the Harvard Medical School and Beth Israel Deaconess Medical Center), together with…
Read more
“… articles go through a lot of drafts, maybe 10-15 drafts, that get passed around between the statisticians and the marketing people at the companies and then, after most of this has already been written, they go looking for the…
Read more
Panorama is a BBC TV programme that specialises in investigative journalism. In 2007 they broadcast “Secrets of the drug trials” (see video below), concerning which the BBC said: “Secret emails reveal that the UK’s biggest drug company distorted trial results…
Read more
Dr. Joan Moncrieff, psychiatrist, writing for the Mad in America website, says: “A few months ago I was surprised to receive a request from an obscure journal of consciousness studies to review a paper. I was surprised because, although it was not immediately…
Read more
A report by Laura Donnelly in The Telegraph (June 2017) notes that: “Four in five GPs believe drug trials are skewed by the pharmaceutical industry, amid widespread mistrust in medical research, polling shows. A report by the Academy of Medical Sciences is…
Read more